Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
Pfizer’s situation with activist investor Starboard Value is already getting messy. | After initially supporting a meeting ...
Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
Investors shrugged as Illumina pressed its case for building on its longtime leadership in next-generation sequencing, ...
Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback